NCT02298959 2026-03-19Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting59 enrolled
NCT02159989 2025-10-20Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1 Completed83 enrolled 21 charts